Eli Lilly (LLY) Reports Q1 2026 Revenue Surge of 56% Following FDA Approval of Foundayo

Eli Lilly and Company (NYSE:LLY) is one of the best growth stocks to invest in for the next 2 years. On April 30, Eli Lilly delivered a powerful performance for Q1 2026, with revenue surging 56% to $19.8 billion. This growth was fueled by a 65% increase in volume, led by the strong demand for the metabolic treatments Mounjaro and Zepbound, which saw worldwide revenues reach $8.7 billion and $4.1 billion, respectively. Despite lower realized prices, the company’s GAAP EPS rose by 170% to $8.26, while non-GAAP EPS reached $8.55.

The quarter was marked by regulatory and clinical milestones, most notably the FDA approval of Foundayo (orforglipron). As the only approved GLP-1 pill without food or water restrictions, Foundayo is expected to broaden patient access to obesity treatments. Lilly also advanced its pipeline with positive Phase 3 results for Jaypirca and retatrutide, and expanded its therapeutic reach through the acquisitions of Orna Therapeutics, Centessa Pharmaceuticals, Kelonia Therapeutics, and Ajax Therapeutics.

Eli Lilly (LLY) Reports Q1 2026 Revenue Surge of 56% Following FDA Approval of Foundayo

Pixabay/Public domain

Reflecting this strong early-year momentum, Eli Lilly and Company (NYSE:LLY) increased its full-year 2026 financial guidance. The company now expects annual revenue to range between $82.0 billion and $85.0 billion, a $2 billion increase from previous estimates. Non-GAAP EPS guidance has also been raised to a range of $35.50 to $37.00.

Eli Lilly and Company (NYSE:LLY) is a healthcare company that develops human pharmaceutical products, including cardiometabolic health, oncology, and immunology products.

While we acknowledge the risk and potential of LLY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than LLY and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.